Affibody Medical Investor Relations
Categories:
Navigation:
Non-Regulatory
August 7, 2012
Interim Report – January to June 2012
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and AlbumodTM,...
Read more
April 29, 2009
Affibody – Interim Report – January to March 2009
Affibody Holding AB (publ) (“Affibody” or “the Company”), a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique...
March 24, 2009
Biovitrum gets access to Affibody® Technology
Affibody AB today signed a collaboration agreement with Biovitrum AB (publ) (STO:BVT) with the aim of developing new targeted therapeutics for inflammation and autoimmune diseases.
February 23, 2009
Year-End Report 2008
Affibody Holding AB (publ) (“Affibody” or “the Company”) today issued its year-end 2008 report. Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic...
